HTA66 Outcomes Examined in Clinical Trials of Medicines for COVID-19: A Review of Regulatory Agencies' Websites
Jul 1, 2022, 00:00
10.1016/j.jval.2022.04.1198
https://www.valueinhealthjournal.com/article/S1098-3015(22)01399-7/fulltext
Title :
HTA66 Outcomes Examined in Clinical Trials of Medicines for COVID-19: A Review of Regulatory Agencies' Websites
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(22)01399-7&doi=10.1016/j.jval.2022.04.1198
First page :
Section Title :
Open access? :
No
Section Order :
11067